Expert Discussion on CAR T Therapy for Relapsed and Refractory Mantle Cell Lymphoma

We hope you found the content valuable; your feedback is very important to us and we appreciate you taking the time to complete this evaluation form.
1.Profession
2.How relevant was this learning program to your practice/role?
3.Overall, how satisfied are you with the quality of the learning content?
4.How satisfied are you that the learning objectives were achieved?

Learning objectives for this program included:
1. Review emerging clinical data and real-world evidence on the use of CAR T therapy in R/R MCL
2. Share best-practices on patient identification, work-up and disease management prior to CAR T infusion
3. Share best-practices on long-term patient management post-infusion
5.How will the learning content support your practice?